CA
CHI Advisors Portfolio holdings
AUM
$252M
This Quarter Return
+22.73%
1 Year Return
+57.46%
3 Year Return
+78.52%
5 Year Return
–
10 Year Return
–
AUM
$256M
AUM Growth
+$256M
(+504%)
Cap. Flow
+$204M
Cap. Flow
% of AUM
79.59%
Top 10 Holdings %
Top 10 Hldgs %
96.91%
Holding
19
New
6
Increased
2
Reduced
9
Closed
–
Top Buys
| 1 |
Repare Therapeutics
RPTX
|
$77.7M |
| 2 |
Pliant Therapeutics
PLRX
|
$74.9M |
| 3 |
AKUS
Akouos, Inc. Common Stock
AKUS
|
$21.9M |
| 4 |
Keros Therapeutics
KROS
|
$21.7M |
| 5 |
Larimar Therapeutics
LRMR
|
$19.5M |
Top Sells
| 1 |
LVGO
Livongo Health, Inc. Common Stock
LVGO
|
$5.64M |
| 2 |
Ovid Therapeutics
OVID
|
$2.09M |
| 3 |
Ultragenyx Pharmaceutical
RARE
|
$2.06M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
$1.87M |
| 5 |
Kezar Life Sciences
KZR
|
$611K |
Sector Composition
| 1 | Healthcare | 99.56% |
| 2 | Communication Services | 0.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Repare Therapeutics
RPTX
$71.7M
| $77.7M | 30.3% | +2,503,408 | New | +$77.7M |
|
|
2
Pliant Therapeutics
PLRX
$101M
| $74.9M | 29.21% | +2,305,994 | New | +$74.9M |
|
|
AKUS
3
DELISTED
Akouos, Inc. Common Stock
AKUS
| $21.9M | 8.56% | +974,985 | New | +$21.9M |
|
|
4
Keros Therapeutics
KROS
$618M
| $21.7M | 8.49% | +579,744 | New | +$21.7M |
|
|
5
Larimar Therapeutics
LRMR
$310M
| $19.5M | 7.6% | +1,515,148 | New | +$19.5M |
|
|
ORTX
6
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $17.6M | 6.86% | 2,931,185 -31,082 | -1% | -$186K |
|
7
Precision BioSciences
DTIL
$57.8M
| $8M | 3.12% | 960,040 +19,480 | +2% | +$162K |
|
|
8
Ovid Therapeutics
OVID
$91M
| $4.01M | 1.57% | 544,281 -284,132 | -34% | -$2.09M |
|
|
9
Kezar Life Sciences
KZR
$28.9M
| $1.77M | 0.69% | 340,973 -117,914 | -26% | -$611K |
|
|
MYOK
10
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $1.3M | 0.51% | 13,500 -1,500 | -10% | -$145K |
|
|
LVGO
11
DELISTED
Livongo Health, Inc. Common Stock
LVGO
| $1.13M | 0.44% | 15,000 -75,000 | -83% | -$5.64M |
|
|
GTHX
12
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $1.07M | 0.42% | +44,000 | New | +$1.07M |
|
13
Adverum Biotechnologies
ADVM
$64.6M
| $1.04M | 0.41% | 50,000 -13,750 | -22% | -$287K |
|
|
14
Ultragenyx Pharmaceutical
RARE
$2.89B
| $1.02M | 0.4% | 13,000 -26,362 | -67% | -$2.06M |
|
15
Corvus Pharmaceuticals
CRVS
$428M
| $990K | 0.39% | 364,132 | – | – |
|
|
BPMC
16
DELISTED
Blueprint Medicines
BPMC
| $936K | 0.37% | 12,000 -24,000 | -67% | -$1.87M |
|
|
GBT
17
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $821K | 0.32% | 13,000 -2,750 | -17% | -$174K |
|
|
BLUE
18
DELISTED
bluebird bio
BLUE
| $488K | 0.19% | 8,000 +2,000 | +33% | +$122K |
|
19
Cogent Biosciences
COGT
$1.69B
| $433K | 0.17% | 940,805 | – | – |
|